“[Organizational and financial aspects of the introduction of Botox® in the clinical diagnostic therapeutic process of chronic migraine at a Local Health Unit in Italy]”, FE, vol. 17, no. 3, Oct. 2016, doi: 10.7175/fe.v17i3.1262.